Captrust Financial Advisors Atri Cure, Inc. Transaction History
Captrust Financial Advisors
- $30 Billion
- Q1 2024
A detailed history of Captrust Financial Advisors transactions in Atri Cure, Inc. stock. As of the latest transaction made, Captrust Financial Advisors holds 7,173 shares of ATRC stock, worth $159,527. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,173
Previous 16,287
55.96%
Holding current value
$159,527
Previous $581,000
62.48%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ATRC
# of Institutions
239Shares Held
46.7MCall Options Held
95.7KPut Options Held
119K-
Vanguard Group Inc Valley Forge, PA4.75MShares$106 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.23MShares$94.1 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.65MShares$81.2 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.68MShares$59.6 Million0.48% of portfolio
-
Wellington Management Group LLP Boston, MA1.64MShares$36.5 Million0.01% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.03B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...